Medical Diagnostic Services. Fermiscan is building an international business specialising in early detection technologies for improved health outcomes.
The Fermiscan Test is a world-first, non- invasive and simple breast cancer screening for women of all ages.
This company has alot of potenetial, no wonder not many people are selling, could be massive in the future, good luck today guys, with the US DOW and so on in the green, and looking more like to strengthen now the crisis is pretty much over, should see some great gains :-) IMO
FER Price at posting:
2.3¢ Sentiment: Buy Disclosure: Held
